About Us
History
1991 | Takiron Co., Ltd. launched its medical division to be prepared for manufacturing and distributing medical devices. | |
---|---|---|
1993 | Manufacturing plant was completed at Takiron Co., Ltd. Yasutomi Factory to produce and distributing bioresorbable materials for osteosynthesis. |
|
1994 | Gained permission to manufacture medical device. To manufacture FIXSORB as a bioresorbable material for osteosynthesis was approved. The sales of FIXSORB started in the field of orthopedic. |
|
1997 | Manufacturing FIXSORB MX mini-plate system as a bioresorbable material for osteosynthesis was approved. The sales of FIXSORB MX started in the fields of oral and maxillofacial/plastic and reconstructive. |
|
1999 | ISO 9001 certification was approved. The sales of FIXSORB MX started in the field of neurosurgery. |
|
2000 | FIXSORB and FIXSORB MX were approved in China. The sales of FIXSORB rib/sternum pins started in the field of thoracic surgeries. |
|
2001 | The second manufacturing plant was completed at Takiron Co., Ltd. Yasutomi Factory. | |
2002 | EN ISO 13485 certification was approved. We expanded to overseas market and the sales of FIXSORB started in China. |
|
2003 | Manufacturing Super FIXSORB 30 as a bioresorbable material for osteosynthesis was approved. Sales started in the field of orthopedic. |
|
2004 | The sales of Super FIXSORB 30 rib/sternum pins started in the field of thoracic surgery. | |
2005 | Gained permission to manufacture and distribute Class 1 medical device. CE marking certificate for OSTEOTRANS-OT and OSTEOTRANS-MX (overseas trade names) as bioactive materials for osteosynthesis was approved. European office opened in Dusseldorf, Germany. |
|
2006 | Manufacturing and distributing Super FIXSORB MX30/MX40 as bioactive bioresorbable material for osteosynthesis was approved, and sales started in the field of oral and maxillofacial. Medical Institute was established in Kobe City Port Island. |
|
2007 | The sales of “Super FIXSORB 30” interference screw started in the field of sports medicine. OSTEOTRANS-OT was launched in Europe. FIXSORB MX was launched in China. |
|
2008 | OSTEOTRANS-OT interference screw was launched in Europe. | |
2009 | The sales of Super FIXSORB MX30/MX40 started in the field of neurosurgery. | |
2011 | European office moved to Berlin, Germany. | |
2013 | OSTEOTRANS-MX was launched in Republic of Korea and Southeast Asia. | |
2014 | European office returned to Dusseldorf, Germany ISO 13485 certification was approved. |
|
2016 | European office was closed. | |
2017 | Teijin Limited took over the medical division of C.I. Takiron Co., Ltd.’s, and established Teijin Medical Technologies Co., Ltd. opening Osaka headquarter and Tokyo Sales Office. Unified quality assurance standards into ISO 13485. |
|
2018 | Medical Institute moved to Okayama from Kobe. |
|
2019 | Manufacturing and Distributing Super FIXSORB EX as abioresorbable material for osteosynthesis was approved, and the sales started in the field of oral and maxillofacial. |
|
2020 | The sales of Super FIXSORB EX started in the field of neurosurgery. |